CA125 measurements are applied in clinical management of ovarian cancer in different situations including early detection, disease monitoring, early prediction of outcome, tumor status after completion of chemotherapy, and early detection of recurrence (55, 56). The gene discussed is MUC16; the disease is ovarian carcinoma.